|

Stefan Somlo, M.D.
C.N.H. Long Professor of Medicine and Genetics.
Chief of Nephrology.
A.B., 1980: Harvard College
M.D., 1984: College of Physicians and Surgeons, Columbia University
Residency: Albert Einstein College of Medicine
Fellowship: Yale University
E-mail: stefan.somlo@yale.edu
We have used our positional cloning-based discovery of three genes mutated
in human polycystic kidney and liver diseases as entry points to
understanding the pathways essential in the development and maintenance
of lumen
forming epithelia. This has led to the discovery that primary apical
cilia serve
essential sensory functions in polarized epithelia. The polycystin-related
pathways serve to maintain the highly structured luminal arrangement
by acting as flow sensors or as lumen diameter sensors. At least
one of the polycystic disease proteins, polycystin-2, functions in other
sensory cilia as well—most notably embryonic nodal cilia that
have a central role in left-right axis determination. We are studying
a series
of engineered mouse models with conditional tissue-specific and inducible
Cre/lox-mediated inactivation of Pkd1, Pkd2, Prkcsh (Pld1) and Pkhd1
to define the actions of the polycystin-related pathways in vivo.
We are using epithelial cell lines lacking these proteins to define
the
intracellular pathways regulated by the polycystin-dependent ciliary
signals. The initial step of polycystin-2 signaling is an increase
in cytosolic Ca2+, but the mechanisms responsible for activation
of the
resultant cellular proliferation and cytoskeletal rearrangements
are the subject of our current studies. In parallel with these efforts,
we continue to pursue positional cloning of additional related human
disease
genes, most notably a second gene for polycystic liver disease.
References
Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE,
Somlo S. (2002) Polycystin-2 is an intracellular calcium release channel.
Nature Cell Biol 4:191-197.
Onuchic L, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C,
Senderek J, Esquivel E, Zeltner R, Rudnick-Schoneborn S, Mrug M, Sweeney
W, Avner E, Zerres K, Guay-Woodford L, Somlo S, Germino G. (2002) PKHD1,
the polycystic kidney and hepatic disease 1 gene encodes a novel large
protein containing multiple IPT domains and PbH1 repeats. Am J Hum Genet.
70:1305-1317.
Wu G, Tian X, Nishimura S, Markowitz GS, D’Agati Y, Hoon-Park
J, Yao L, Li L, Geng L, Zhaou H, Edelmann W, Somlo S. (2002) Trans-heterozygous
Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
Hum Mol Genet, 11:1845-1854.
Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston J 3rd, Shub C, Davila
S, Somlo S, Torres VE. (2003) Clinical profile of autosomal dominant
polycystic liver disease. Hepatology, 37:164-171.
Li A, Davila S, Furu L, Qian Q, Tian X, Kamath PS, King BF Torres VE,
and Somlo S. (2003) Mutations in PRKCSH cause isolated autosomal dominant
polycystic liver disease. Am J Hum Genet, 72:691-703.
Lin F, Hiesberger T, Cordes K, Sinclair AM, Goldstein LSB, Somlo S,
and Igarashi P. (2003) Kidney-specific inactivation of KIF3A subunit
of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney
disease. Proc Natl Acad Sci U.S.A., 100:5286-91.
McGrath J, Somlo S, Makova S, Tian X, and Brueckner M. (2003) Two populations
of node monocilia initiate left-right asymmetry in the mouse. Cell, 114:61-73.
Furu L, Onuchic LF, Gharavi A, Hou X, Esquivel EL, Nagasawa Y, Bergmann
C, Senderek J, Avner E, Zerres KZ, Germino GG, Guay-Woodford LM, and
Somlo S. (2003) Milder presentation of recessive polycystic kidney disease
requires presence of amino acid substitution mutations. J Am Soc Nephrol,
14:2004-14.
|
|